« Back to Record
Citation APA

Bedard, P. L., Singhal, S. K., Ignatiadis, M., Bradbury, I., Haibe-Kains, B., Desmedt, C., Loi, S., Evans, D. B., Michiels, S., Dixon, J. M., Miller, W. R., Piccart-Gebhart, M., & Sotiriou, C. (2011). Low residual proliferation after short-term letrozole therapy is an early predictive marker of response in high proliferative ER-positive breast cancer. Endocrine-related cancer, 18(6), 721-730. doi:10.1530/ERC-11-0180


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/113280

Bedard, P. L., Singhal, S. K., Ignatiadis, M., Bradbury, I., Haibe-Kains, B., Desmedt, C., Loi, S., Evans, D. B., Michiels, S., Dixon, J. M., Miller, W. R., Piccart-Gebhart, M., & Sotiriou, C. (2011). Low residual proliferation after short-term letrozole therapy is an early predictive marker of response in high proliferative ER-positive breast cancer. Endocrine-related cancer, 18(6), 721-730. doi:10.1530/ERC-11-0180